Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29102792 | 0.88 | DUT (0.41) | DUT | |
| SCHEMBL852468 | 0.87 | DUT (0.40) | DUT | |
| SCHEMBL201004 | 0.85 | DUT (0.39) | DUT | |
| SCHEMBL2917304 | 0.84 | TSHR (0.40) | DUT | |
| SCHEMBL27241090 | 0.84 | TSHR (0.40) | DUT | |
| SCHEMBL31240526 | 0.84 | TSHR (0.40) | DUT | |
| SCHEMBL1008596 | 0.84 | TSHR (0.40) | DUT | |
| SCHEMBL5889630 | 0.82 | DUT (0.31) | DUT | |
| SCHEMBL18377988 | 0.81 | DUT (0.33) | DUT | |
| SCHEMBL14244960 | 0.81 | DUT (0.33) | DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 721 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119822916-A | Chiral alpha-aryl alkyne compound and synthesis method thereof | 同济大学 | 2025-04-15 | — | — | CN | claimed |
| WO-2026103814-A1 | IRREVERSIBLE FAP INHIBITOR AND USE THEREOF | 南京科络思生物科技有限公司 | 2026-05-21 | — | — | WO | disclosed |
| EP-4728073-A1 | OLIGONUCLEOTIDE FORMULATION | Ractigen Therapeutics (CN) | 2026-04-22 | — | — | EP | disclosed |
| EP-4689615-A2 | BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC ACTIVATION | Promega Corporation (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4680609-A1 | KRAS MODULATORS AND USES THEREOF | Quanta Therapeutics, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| US-12522615-B2 | Macrocyclic compounds and derivatives as EGFR inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2026-01-13 | — | — | US | disclosed |
| WO-2025264818-A1 | STAT6 MODULATORS AND METHODS OF USES THEREOF | RAYTHERA, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| US-20250388568-A1 | NLRP3 INHIBITORS | KODIAK SCIENCES INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250387397-A1 | SUBSTITUTED AMINO TRIAZOLOPYRIMIDINE AND AMINO TRIAZOLOPYRAZINE ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE | MERCK SHARP & DOHME LLC (US) | 2025-12-25 | — | — | US | disclosed |
| EP-3883576-B1 | SUBSTITUTED AMINO TRIAZOLOPYRIMIDINE AND AMINO TRIAZOLOPYRAZINE ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE | MERCK SHARP & DOHME LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| EP-0532423-A1 | Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-03-17 | — | — | EP | disclosed |
| US-5142039-A | β-lactam antibiotics | ELI LILLY AND COMPANY (US) | 1992-08-25 | — | — | US | disclosed |
| WO-1992001698-A1 | ANTIVIRAL PHOSPHONO-ALKEN DERIVATIVES OF PURINES | BEECHAM GROUP PLC (GB) | 1992-02-06 | — | — | WO | disclosed |
| US-5004753-A | Novel carboxylic acid esters, method for their production and insecticides containing them as active ingredient | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-04-02 | — | — | US | disclosed |
| US-4983732-A | CEHMICAL INTERMEDIATES FOR BETA-LACTAM ANTIBIOTICS | ELI LILLY AND COMPANY (US) | 1991-01-08 | — | — | US | disclosed |
| US-4892942-A | 1-CARBA (DETHIA)CEPHALOSPORINS | ELI LILLY AND COMPANY (US) | 1990-01-09 | — | — | US | disclosed |
| EP-0301877-A1 | A method of deprotection of 3-amino azetidinones | ELI LILLY AND COMPANY (US) | 1989-02-01 | — | — | EP | disclosed |
| US-4791106-A | 1-Carbacephalosporin antibiotics | ELI LILLY AND COMPANY (US) | 1988-12-13 | — | — | US | disclosed |
| EP-0291045-A2 | Novel carboxylic acid esters, method for their production and insecticides containing them as an active ingredient | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-11-17 | — | — | EP | disclosed |
| EP-0232623-A1 | 1-Carbacephalosporin antibiotics | ELI LILLY AND COMPANY (US) | 1987-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388568-A1 | NLRP3 INHIBITORS | NLRP3, NOD1, NLRP1 | DUT 4628/4885ALDH1A1 3213/4885 |
| US-20250387397-A1 | SUBSTITUTED AMINO TRIAZOLOPYRIMIDINE AND AMINO TRIAZOLOPYRAZINE ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE | ADORA2A, ADORA2B, ADORA1 | DUT 933/4885ALDH1A1 291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.